// App-Quantinova.ai

: Cervical Dystonia Patients Treated with OnabotulinumtoxinA Report Improvements in Health-Related Quality of Life in a Multicentre, Prospective, Observational Study: POSTURe (P5.052)

Researchers

Presenter

  • Marc Petitclerc

Principal Investigators

  • Martin Cloutier

  • Meetu Bhogal

  • Goran Davidovic

Medical Centers

  • 1Polyclinique Médicale Des Ponts Saint?Romuald QC Canada

  • 3Allergan plc Markham ON Canada

  • 22Clinique Neuro-Rive Sud Greenfield Park QC Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • OnabotulinumtoxinA

Outcome

  • N/A


Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A